Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

074IC - AUA Castration-Resistant Prostate Cancer (CRPC) Guidelines

Monday, May 21
1:30 PM - 3:30 PM
Location: MCC WEST, 2002

This course will review the 2015 update to the 2013 AUA guidelines on castration-resistant prostate cancer. Faculty will explore the rigorous process used in the development of these evidence-based guidelines, as well as discuss new developments and future research needs for this topic. The course will showcase clinical scenarios in urological practice and the correct application of the new AUA guidelines in those instances. This course will be a benefit to practicing urologists, non-physician providers, residents preparing for their certification exam and physicians preparing for their re-certification exam.

Learning Objectives:

Michael S. Cookson

University of Oklahoma

Michael S. Cookson, M.D. is Professor and Chairman of the Department of Urology at the University of Oklahoma Health Sciences Center and holds the Donald D. Albers Endowed Chair in Urology. An accomplished researcher and lecturer, he is the author of 250 peer-reviewed journal publications and chapters of various textbooks in urology and urologic surgery, and is recognized nationally for outstanding contributions to urologic oncology.
Dr. Cookson completed his Urology residency at the University of Texas, San Antonio and completed his Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. He was a member of the faculty at Vanderbilt University from 1998 to 2013, where he served as the Vice Chairman of Urologic Surgery and Director of the Urologic Oncology Fellowship Program.
Dr. Cookson has devoted a significant portion of his academic career to the management of patients with urologic cancers, with a strong emphasis on Clinical Guidelines, Education and Evidenced Based Medicine. He was a member of the AUA/ABU examination committee for 10 years, including Task for Cancer, Oncology Consultant and Pathology editor. He also serves on the ABU Oral Examination Committee. He is a co-founder of the OKAT, an SUO mandated oncology examination that is the standard for benchmarking for members and oncology fellows in training and served as Chair of that OKAT committee for 5 years. In 2011, he received the President’s Distinguished Service Award from the SUO for educational contributions. For his efforts in teaching at Vanderbilt, he was awarded the Michael Rodriquez Award.
Dr. Cookson recently served as the Chair of the AUA Guidelines Committee on Castration Resistant Prostate Cancer, and has previously served as the member of the AUA Guidelines on localized prostate cancer. He served as Treasurer for the SUO and is the SUO President Elect for 2018-2019.

Presentation(s):

Send Email for Michael Cookson

David Jarrard

University of Wisconsin

David Frazier Jarrard, MD, is a tenured Professor and Vice Chair in Urology at the University of Wisconsin and an Associate Director in the UW Carbone Cancer Center. He obtained his BA and MD from the University of Virginia and completed a Urologic Surgery residency at the University of Chicago Hospitals. He was a fellow in Urologic Oncology at the Brady Urologic Institute of the Johns Hopkins Hospital. He is currently leads the division of Urologic Oncology, and holds the John Livesey Chair in Urologic Oncology. Dr. Jarrard has served on numerous American Urological Association committees and is President-Elect for the North Central Section. He is Past President for the Society for Basic Urologic Research (SBUR) and serves on the boards of the Society for Urologic Oncology (Member at large) and Society for Academic Urology (Treasurer).

He has active basic science and translational research interests supported through the National Institutes of Health and the Department of Defense Prostate Cancer Research Programs examining epigenetic factors underlying prostate cancer development and novel approaches to treating advanced disease. His clinical work concentrates on advanced Urologic Oncology and improving cancer detection and outcomes. Awards include the SBUR Young Investigator and Distinguished Service Awards, Madison Magazine’s ‘Best Physicians in Wisconsin’, Castle Connolly ‘Top Doctors’, ‘Best Doctor in America™’ and the Society for Urologic Oncology Distinguished Service Award. Dr. Jarrard has published numerous chapters, articles and abstracts in the field of prostate cancer.


Presentation(s):

Send Email for David Jarrard

Adam Kibel

Harvard University

Adam S. Kibel, MD is Chief of Urologic Surgery at both the Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, Massachusetts. In addition, he is Elliot Carr Culter Professor of Surgery at Harvard University School of Medicine. Chairman of the Harvard Program in Urology Residency Program and Co-Leader of the Prostate Cancer Program for Dana Farber/Harvard Cancer Center. Dr Kibel received his undergraduate and medical degrees from Cornell University, completed his urology residency at the Harvard Urology Program, and his fellowship at the Brady Urologic Institute at Johns Hopkins in Baltimore, Maryland.

Dr. Kibel’s practice focused on minimally invasive treatments for urologic cancers. With over 190 peer reviewed publications, Dr Kibel’s research focuses on the identification of molecular markers of urologic tumors, integration of systemic agents earlier in the disease process and improved imaging of patients with urologic malignancies. His research has been supported by the National Cancer Institute, American Cancer Society, American College of Surgeons, and the American Foundation for Urologic Disease.

Presentation(s):

Send Email for Adam Kibel


Assets

074IC - AUA Castration-Resistant Prostate Cancer (CRPC) Guidelines

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for AUA Castration-Resistant Prostate Cancer (CRPC) Guidelines